AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,575 Cr | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr |
What is the latest Total Liabilities ratio of AARTI DRUGS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,575 Cr |
| Mar2024 | ₹2,432 Cr |
| Mar2023 | ₹2,421 Cr |
| Mar2022 | ₹2,208 Cr |
| Mar2021 | ₹1,766 Cr |
How is Total Liabilities of AARTI DRUGS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,575 Cr | 5.85 | |
| Mar2024 | ₹2,432 Cr | 0.45 | |
| Mar2023 | ₹2,421 Cr | 9.67 | |
| Mar2022 | ₹2,208 Cr | 25.02 | |
| Mar2021 | ₹1,766 Cr | - | |
Compare Total Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,895.8 Cr | -2.1% | -2.5% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -2.1% |
-2.5% |
-12.9% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses